Related Experiment Video
Updated: Jun 30, 2026

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
Published on: April 1, 2015
Thrombosis and fibrinolysis in acute myocardial infarction
1Cardiovascular Division, Washington University School of Medicine, St. Louis, MO 63110.
Insights
Coronary thrombosis, triggered by atherosclerotic plaque rupture, leads to acute myocardial infarction. Novel antithrombotic interventions targeting coagulation and fibrinolysis show promise for inhibiting thrombosis progression.
Area of Science:
- Cardiovascular Medicine
- Hematology
- Pathophysiology
Background:
- Atherosclerotic plaque rupture initiates coronary thrombosis, a key event in evolving stable coronary disease to acute myocardial infarction.
- The tissue factor pathway of coagulation and platelet adhesion are critical in initiating thrombosis.
- Procoagulant and fibrinolytic activity modulate thrombosis extent, with imbalances posing risks for myocardial infarction.
Purpose of the Study:
- To provide insight into the mechanisms of thrombosis following atherosclerotic plaque rupture.
- To identify novel antithrombotic interventions for coronary thrombosis.
Main Methods:
- Review of recent studies on coronary thrombosis mechanisms.
- Analysis of factors modulating procoagulant and fibrinolytic activity.
Main Results:
- Confirmed the critical role of tissue factor pathway activation and platelet adhesion in thrombosis initiation.
- Highlighted that altered procoagulant and fibrinolytic activity significantly influence thrombosis severity.
- Recent research offers insights into thrombosis mechanisms and potential therapeutic targets.
Conclusions:
- Understanding thrombosis mechanisms post-plaque rupture is crucial for managing acute myocardial infarction.
- Novel antithrombotic strategies targeting coagulation and fibrinolysis are being developed to inhibit coronary thrombosis progression.
Abstract:
The development of coronary thrombosis in response to rupture of atherosclerotic plaques is the primary determinant of the evolution of stable atherosclerotic coronary disease to unstable ischemic syndromes and acute myocardial infarction. Activation of the tissue factor pathway of coagulation and adhesion of platelets are critical events in the initiation of thrombosis. However, subsequently, other factors may determine the extent of thrombosis by modulating the intensity of procoagulant and fibrinolytic activity. Marked procoagulant activity, attenuation of physiologic fibrinolytic activity, or both appear to be risk factors for myocardial infarction. The results of recent studies have provided considerable insight into potential mechanisms for thrombosis in response to rupture of atherosclerotic plaque and have identified potential novel antithrombotic interventions to inhibit the progression of coronary thrombosis.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Clot Retraction and Fibrinolysis
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome IV: Interprofessional Care
Venous Thrombosis III: Interprofessional Care

